TCTR20231017001招募中4 期
Antibody persistence against diphtheria, tetanus, pertussis, hepatitis B, measles, mumps and rubella in 5-8-year-old Thai children following primary and first booster immunization with pentavalent vs. hexavalent vaccines
ational Reserach Council of Thailand (NRCT)0 个研究点目标入组 200 人开始时间: 2023年10月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 Years 至 6 Years（—）
- 性别
- All
入选标准
- •Health children who were enrolled in the original trial (ClinicalTrials.gov NCT02408926, TCTR20180926001 ) and received four doses of either DTaP-IPV-HB-Hib or DTwP-HB-Hib + bOPV as primary series and first booster vaccination, and Tdap-IPV as second booster vaccination at the age of four years.
排除标准
- •1. Immunocompromised status
- •2. Bleeding tendency
- •3. Parent refusal to participate
研究者
相似试验
尚未招募
不适用
Antibody persistence against diphtheria, tetanus, pertussis, hepatitis B, measles, mumps and rubella in 9-12-year-old Thai children following immunization with pentavalent and hexavalent vaccines, and the immunogenicity of Tdap administered at 11 years of ageChildren aged 9-12 years who are healthy with previous immunization with either pentavalent or hexavalent vaccines. Informed consent obtained from parents/guardians.hepatitis BmeaslespertussistetanusdiphtheriarubellamumpsTCTR20240723005Ratchadapiseksomphot Endowment Fund, Chulalongkorn University250
进行中（未招募）
不适用
Immunogenicity and safety of a tetanus, diphtheria and mono component acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as a booster vaccination to adultsThe intended use of the vaccine in this study is to increase the immunological protection against pertussis in adults who completed primary vaccination with diphtheria, tetanus and pertussis vaccine typically during their childhood.MedDRA version: 12.0Level: LLTClassification code 10034738Term: PertussisEUCTR2009-013411-36-DKStatens Serum Institut
招募中
不适用
Immune response after diphtheria and tetanus toxoid booster in patients with adult onset immunodeficiency with anti-interferon gamma autoantibodyInterferon gamma autoantibodyinterferon gamma autoantibodyDiphtheria toxoidTetanus toxoidImmune responseTCTR20190422001Ratchadapiseksompoch funds36
进行中（未招募）
不适用
Safety and Immunogenicity of ADACEL™ (TdcP Vaccine) Compared with QUADRACEL™ (HCPDT-mIPV Vaccine) as Fifth Dose in Children 4-6 Years of AgeEUCTR2015-005589-43-Outside-EU/EEASanofi Pasteur Limited600
已完成
不适用
Evaluation of the immune system response to Diphtheria and Tetanus vaccination in HIV positive patientsHIV AIDS.Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesIRCT201211204076N8Resaerch Deputy tehran university of medical sciences300